Table 3. Tracking the amount of virus present in cells infected with HRSV following administering shRNA and ribavirin as part of a course of treatment over a period of time .

Vector or ribavirin concentrations	Viral load (copies/mL)/hours post-treatment
	24	48	72	96
Untreated control	4.5 × 105	4.2 × 106	5.2 × 107	6.1 × 108
scramble control (20 nM)	4.4 × 105	4.1 × 106	5.0 × 107	6.0 × 108
shRNA targeting HRSV-M gene (10 nM) (5 nM)	3.7 × 105	2.9 × 105	7.5 × 104	9.2 × 103
	4.1 × 105	3.5 × 105	7.9 × 104	10.1 × 103
shRNA targeting HRSV-F gene (10 nM)	3.9 × 105	3.2 × 105	8.0 × 104	10.2 × 103
(5 nM)	4.2 × 105	3.7 × 105	8.3 × 104	10.2 × 103
Ribavirin (150 µM)	3.6 × 105	6.2 × 104	3.2 × 104	9.1 × 103
(100 µM)	4.0 × 105	3.0 × 105	7.5 × 104	9.9 × 103
Ribavirin (150 µM) + shRNA targeting HRSV-M gene (10 nM)	3.4 × 105	4.5 × 104	2.5 × 104	6.9 × 103
Ribavirin (150 µM) + shRNA targeting HRSV-F gene (10 nM)	3.5 × 105	5.1 × 104	3.0 × 104	7.5 × 103
shRNA targeting HRSV-M gene (10 nM) + shRNA targeting HRSV-F gene (10 nM)	3.6 × 105	4.7 × 104	2.6 × 104	7.0 × 103